XML 33 R12.htm IDEA: XBRL DOCUMENT v3.25.4
INVESTMENT IN ASSOCIATE
 12 Months Ended
Dec. 31, 2025
Disclosure of associates [abstract]  
INVESTMENT IN ASSOCIATE
 
7.
INVESTMENT IN ASSOCIATE
 
Balance at December 31, 2023
   
$
240,116
 
Loss on dilution of ownership interest in associate
      (113)  
Share of net loss from associate
      (13,798)  
Share of other comprehensive income from associate
      3,389  
Balance at December 31, 2024
   
$
229,594
 
Loss on dilution of ownership interest in associate
   
 
(11,481)
 
Share of net loss from associate
   
 
(279)
 
Share of other comprehensive loss from associate
   
 
(1,230)
 
Acquisition of additional investment in associate
   
 
18,250
 
Impairment loss
   
 
(81,009)
 
Balance at December 31, 2025
   
$
153,845
 
Fair value of investment in associate as at December 31, 2025
   
$
  205,820
 
The fair value of the investment in associate as at December 31, 2025 is measured using the closing market price of IsoEnergy on December 31, 2025. On March 20, 2025, IsoEnergy completed a 4:1 common share consolidation. The Company performs an impairment indicator assessment on its investment in IsoEnergy at each period end. The assessment is based on the review of observable data indicating whether one or more events have occurred since the initial recognition of the investment that have impacted the estimated future cash flows from the net investment and can be reliably estimated. The observable data reviewed includes, but is not limited to recent share price history indicating a significant or prolonged decline in the share price of the associate. On March 31, 2025, the Company determined the carrying value of its investment in IsoEnergy had become impaired due to the significant and prolonged decline in the fair value of the IsoEnergy shares as a result of macroeconomics circumstances and recorded a loss of $81,009.
 
 
Summarized financial information for IsoEnergy is as follows:
 
     
   December 31, 2025
   December 31, 2024
Cash
   
$
62,906
  
   $ 21,295   
Other current assets
   
 
2,659
 
     7,110  
Marketable securities
   
 
53,452
 
     31,181  
Non-current
assets
   
 
297,941
 
     281,249  
Total assets
   
$
416,958
 
   $ 340,835  
                  
Current liabilities
   
 
12,399
 
     35,104  
Non-current
liabilities
   
 
3,133
 
     2,568  
Total liabilities
   
$
      15,532
 
   $        37,672  
 
     
Year ended
Dec 31, 2025
     
Year ended
Dec 31, 2024
  
Net loss
   
$
(1,127) 
   $ (42,135)   
Other comprehensive income (loss)
   
$
(3,636) 
   $ 10,172   
Total comprehensive loss
   
$
        
 (4,763)
 
   $         (31,963)